Showing results (81-90 of 145) with videos related to

Sort By:
Pageof 15
Nano Letters|July 9, 2009
Recombination dynamics of spatially confined electron-hole system in luminescent gold catalyzed silicon nanowiresO Demichel, V Calvo, N Pauc, et al.
Human & Experimental Toxicology|November 5, 1997
Organotin compounds in trimethyltin-treated rats and in human brain in Alzheimer's diseaseF Martin, F M Corrigan, O F Donard, et al.
The British Journal of Psychiatry : the Journal of Mental Science|March 1, 1987
The psychological well-being of supporters of the demented elderlyJ M Eagles, A Craig, F Rawlinson, et al.
Cell Biology and Toxicology|February 1, 1997
Comparison of amitriptyline metabolism in hepatocytes from streptozocin-induced diabetic rats and from non-diabetic ratsF Coudoré, A Besson, R Shrivastava, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 1, 1992
Estimation of premorbid intelligence in schizophreniaJ R Crawford, J A Besson, M Bremner, et al.
Acta Neurologica Scandinavica|April 1, 1990
Parkinson's disease in Aberdeen: survival after 3.5 yearsK P Ebmeier, S A Calder, J R Crawford, et al.
The British Journal of Psychiatry : the Journal of Mental Science|September 1, 1988
Brain imaging and treatment response in spasmodic torticollisJ A Besson, K P Ebmeier, H G Gemmell, et al.
Neurology|August 1, 1990
Clinical features predicting dementia in idiopathic Parkinson's disease: a follow-up studyK P Ebmeier, S A Calder, J R Crawford, et al.
Scottish Medical Journal|December 1, 1990
Mortality and causes of death in idiopathic Parkinson's disease: results from the Aberdeen whole population studyK P Ebmeier, S A Calder, J R Crawford, et al.
Psychological Medicine|February 1, 1991
Dementia in idiopathic Parkinson's disease: prevalence and relationship with symptoms and signs of parkinsonismK P Ebmeier, S A Calder, J R Crawford, et al.
Pageof 15